GSK plans $30bn investment for R&D in US
The investment includes a $1.2bn package for advanced manufacturing, AI and digital technologies.

The investment includes a $1.2bn package for advanced manufacturing, AI and digital technologies.
Trump has asked pharma companies to justify efficacy for their Covid-19 drugs as he attempts to quell unrest in his administration.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Oxford University and Ellison Institute link for AI vaccine research
FDA approves mRNA vaccines for new Covid-19 season amid political tension
AI psychosis sees users ‘co-creating delusions with technology’ – expert
Opadry complete film coating system: 45 years of trust, innovation and performance